National HealthCare Management

Management Kriterienprüfungen 3/4

National HealthCare's CEO ist Steve Flatt , ernannt in Jan 2017, hat eine Amtszeit von 7.42 Jahren. Die jährliche Gesamtvergütung beträgt $1.61M , bestehend aus 32.8% Gehalt und 67.2% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.4% der Aktien des Unternehmens, im Wert von $6.39M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 7.3 Jahre bzw. 20.8 Jahre.

Wichtige Informationen

Steve Flatt

Geschäftsführender

US$1.6m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	32.8%
Amtszeit als Geschäftsführer	7.5yrs
Eigentum des Geschäftsführers	0.4%
Durchschnittliche Amtszeit des Managements	7.4yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder	20.9yrs

Jüngste Management Updates

Recent updates

Why We Think National HealthCare Corporation's (NYSEMKT:NHC) CEO Compensation Is Not Excessive At All

May 01

Returns On Capital At National HealthCare (NYSEMKT:NHC) Paint A Concerning Picture

Apr 09

Is National HealthCare Corporation (NYSEMKT:NHC) A Good Fit For Your Dividend Portfolio?

Mar 17

National HealthCare Corporation's (NYSEMKT:NHC) Stock Going Strong But Fundamentals Look Weak: What Implications Could This Have On The Stock?

Mar 02

National HealthCare Corporation (NYSEMKT:NHC) Insiders Have Been Selling

Feb 15

Reflecting on National HealthCare's (NYSEMKT:NHC) Share Price Returns Over The Last Year

Feb 02

Could The National HealthCare Corporation (NYSEMKT:NHC) Ownership Structure Tell Us Something Useful?

Jan 20

These Metrics Don't Make National HealthCare (NYSEMKT:NHC) Look Too Strong

Jan 07

Do These 3 Checks Before Buying National HealthCare Corporation (NYSEMKT:NHC) For Its Upcoming Dividend

Dec 25

What We Learned About National HealthCare's (NYSEMKT:NHC) CEO Pay

Dec 24

Is National HealthCare Corporation's (NYSEMKT:NHC) 3.1% Dividend Worth Your Time?

Dec 12

Does National HealthCare Corporation's (NYSEMKT:NHC) Weak Fundamentals Mean A Downturn In Its Stock Should Be Expected?

Nov 30

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Steve Flatt im Vergleich zu den Einnahmen von National HealthCare verändert?
Datum	Gesamtvergütung	Gehalt	Unternehmensgewinne
Mar 31 2024	n/a	n/a	US$81m
Dec 31 2023	US$2m	US$528k	US$67m
Sep 30 2023	n/a	n/a	US$45m
Jun 30 2023	n/a	n/a	US$32m
Mar 31 2023	n/a	n/a	US$19m
Dec 31 2022	US$1m	US$522k	US$22m
Sep 30 2022	n/a	n/a	US$32m
Jun 30 2022	n/a	n/a	US$31m
Mar 31 2022	n/a	n/a	US$133m
Dec 31 2021	US$2m	US$498k	US$139m
Sep 30 2021	n/a	n/a	US$150m
Jun 30 2021	n/a	n/a	US$167m
Mar 31 2021	n/a	n/a	US$90m
Dec 31 2020	US$1m	US$476k	US$42m
Sep 30 2020	n/a	n/a	US$28m
Jun 30 2020	n/a	n/a	US$35m
Mar 31 2020	n/a	n/a	US$20m
Dec 31 2019	US$1m	US$495k	US$68m
Sep 30 2019	n/a	n/a	US$73m
Jun 30 2019	n/a	n/a	US$74m
Mar 31 2019	n/a	n/a	US$83m
Dec 31 2018	US$1m	US$393k	US$59m
Sep 30 2018	n/a	n/a	US$62m
Jun 30 2018	n/a	n/a	US$52m
Mar 31 2018	n/a	n/a	US$41m
Dec 31 2017	US$1m	US$145k	US$56m

Vergütung im Vergleich zum Markt: SteveDie Gesamtvergütung ($USD1.61M) liegt unter dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt US ($USD5.67M).

Entschädigung vs. Einkommen: SteveDie Bezüge der Mitarbeiter sind im vergangenen Jahr um mehr als 20 % gestiegen.

Geschäftsführer

Steve Flatt (68 yo)

7.5yrs

Amtszeit

US$1,609,695

Vergütung

Dr. Stephen F. Flatt, also known as Steve, has been the Chief Executive Officer of National HealthCare Corporation since January 1, 2017. Dr. Flatt served as the President of National Healthcare Corporatio...

Führungsteam

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Stephen Flatt	CEO & Director	7.5yrs	US$1.61m	0.40% $ 6.6m
R. Ussery	President & COO	15.5yrs	US$1.49m	0.99% $ 16.5m
Brian Kidd	Senior VP & CFO	no data	US$815.48k	0.15% $ 2.6m
B. Flatt	Senior VP & Chief Information Officer	7.4yrs	US$767.33k	0.079% $ 1.3m
Josh McCreary	Senior VP	5.3yrs	US$813.94k	0.044% $ 727.3k
Carl Adams	Founder	no data	keine Daten	keine Daten
Vicki Dodson	Senior Vice President of Patient Services	5.1yrs	keine Daten	0.045% $ 754.7k

7.4yrs

Durchschnittliche Betriebszugehörigkeit

62yo

Durchschnittliches Alter

Erfahrenes Management: NHCDas Führungsteam des Unternehmens verfügt über eine langjährige Erfahrung (7.3 ).

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Stephen Flatt	CEO & Director	7.5yrs	US$1.61m	0.40% $ 6.6m
W. Adams	Independent Director	50.5yrs	US$189.88k	4.54% $ 75.8m
Robert Adams	Independent Chairman	15.5yrs	US$192.88k	2.83% $ 47.3m
Richard LaRoche	Independent Director	22.5yrs	US$204.88k	2.31% $ 38.5m
Ernest Burgess	Independent Director	32.5yrs	US$192.88k	0.56% $ 9.3m
Emil Hassan	Independent Director	20.3yrs	US$196.88k	0.47% $ 7.9m
James Abernathy	Independent Director	21.5yrs	US$196.88k	0.23% $ 3.8m
Sandra Trail	Independent Director	2.4yrs	US$192.88k	0.023% $ 391.8k

20.9yrs

Durchschnittliche Betriebszugehörigkeit

77.5yo

Durchschnittliches Alter

Erfahrener Vorstand: NHCDie Vorstandsmitglieder sind sehr erfahren ( 20.8 ).

National HealthCare Management

Management Kriterienprüfungen 3/4

Wichtige Informationen

Jüngste Management Updates

Independent Director exercised options to buy US$420k worth of stock.

National HealthCare Corporation, Annual General Meeting, May 09, 2024

Independent Director exercised options to buy US$312k worth of stock.

Independent Chairman exercised options to buy US$290k worth of stock.

Independent Director recently sold US$641k worth of stock

Independent Director exercised options to buy US$131k worth of stock.

Recent updates

Upcoming dividend of US$0.61 per share

First quarter dividend increased to US$0.61

National Healthcare Corporation Declares Quarterly Dividend, Payable on August 1, 2024

First quarter 2024 earnings released: EPS: US$1.71 (vs US$0.76 in 1Q 2023)

Independent Director exercised options to buy US$420k worth of stock.

National HealthCare Corporation, Annual General Meeting, May 09, 2024

Upcoming dividend of US$0.59 per share

New minor risk - Earnings quality

Full year 2023 earnings released: EPS: US$4.36 (vs US$1.46 in FY 2022)

Third quarter dividend of US$0.59 announced

NHC Announces Quarterly Common Dividend, Payable on May 1, 2024

Independent Director exercised options to buy US$312k worth of stock.

Upcoming dividend of US$0.59 per share at 2.5% yield

Independent Chairman exercised options to buy US$290k worth of stock.

Independent Director recently sold US$641k worth of stock

Third quarter 2023 earnings released: EPS: US$0.68 (vs US$0.16 loss in 3Q 2022)

National Healthcare Corporation Announces Quarterly Dividend, Payable on February 1, 2024

Independent Director exercised options to buy US$131k worth of stock.

Upcoming dividend of US$0.59 per share at 3.5% yield

Independent Chairman recently bought US$131k worth of stock

New major risk - Revenue and earnings growth

Second quarter 2023 earnings released: EPS: US$1.06 (vs US$0.21 in 2Q 2022)

National Healthcare Corporation Announces Quarterly Dividend, Payable on November 1, 2023

Independent Director recently bought US$129k worth of stock

Upcoming dividend of US$0.59 per share at 3.9% yield

Independent Director recently bought US$135k worth of stock

National HealthCare Corporation Announces Quarterly Dividend, Payable on July 31, 2023

First quarter 2023 earnings released: EPS: US$0.76 (vs US$0.99 in 1Q 2022)

Upcoming dividend of US$0.57 per share at 4.1% yield

Independent Director recently bought US$125k worth of stock

Full year 2022 earnings released: EPS: US$1.46 (vs US$9.03 in FY 2021)

National Healthcare Corporation Declares Quarterly Dividend, Payable on May 1, 2023

Upcoming dividend of US$0.57 per share

Independent Director exercised options to buy US$106k worth of stock.

Independent Director recently sold US$211k worth of stock

Insufficient new directors

National HealthCare Corporation Announces Quarterly Dividend, Payable on February 1, 2023

Third quarter 2022 earnings released: US$0.16 loss per share (vs US$0.22 loss in 3Q 2021)

Upcoming dividend of US$0.57 per share

Independent Director exercised options to buy US$175k worth of stock.

National HealthCare Corporation (NYSEAM:NHC) announces an Equity Buyback for $25 million worth of its shares.

Second quarter 2022 earnings released: EPS: US$0.21 (vs US$6.83 in 2Q 2021)

National Healthcare Corporation Announces Quarterly Dividend, Payable on November 1, 2022

Upcoming dividend of US$0.57 per share

Independent Chairman exercised options to buy US$135k worth of stock.

Independent Director exercised options to buy US$529k worth of stock.

First quarter 2022 earnings released: EPS: US$0.99 (vs US$1.39 in 1Q 2021)

National Healthcare Corporation Announces Quarterly Dividend, Payable on August 1, 2022

Insufficient new directors

Upcoming dividend of US$0.55 per share

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

National Healthcare Corporation Announces Quarterly Dividend, Payable on May 2, 2022

National HealthCare Corporation Appoints Sandra Y. Trail to Its Board of Director, Effective February 1, 2022

Independent Director exercised options to buy US$350k worth of stock.

Upcoming dividend of US$0.55 per share

CEO & Director exercised options and sold US$132k worth of stock

Third quarter 2021 earnings released: US$0.22 loss per share (vs US$0.84 profit in 3Q 2020)

Upcoming dividend of US$0.52 per share

Second quarter 2021 earnings released: EPS US$6.83 (vs US$1.85 in 2Q 2020)

Upcoming dividend of US$0.52 per share

Independent Director exercised options to buy US$567k worth of stock.

First quarter 2021 earnings released: EPS US$1.39 (vs US$1.76 loss in 1Q 2020)

National Healthcare Corporation Announces Quarterly Dividend, Payable on August 2, 2021

Independent Director exercised options to buy US$527k worth of stock.

Why We Think National HealthCare Corporation's (NYSEMKT:NHC) CEO Compensation Is Not Excessive At All

Returns On Capital At National HealthCare (NYSEMKT:NHC) Paint A Concerning Picture

Upcoming Dividend of US$0.52 Per Share

Independent Director recently sold US$151k worth of stock

Is National HealthCare Corporation (NYSEMKT:NHC) A Good Fit For Your Dividend Portfolio?